These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11483141)

  • 1. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
    Carroll KM; Ball SA; Nich C; O'Connor PG; Eagan DA; Frankforter TL; Triffleman EG; Shi J; Rounsaville BJ
    Arch Gen Psychiatry; 2001 Aug; 58(8):755-61. PubMed ID: 11483141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral family counseling and naltrexone for male opioid-dependent patients.
    Fals-Stewart W; O'Farrell TJ
    J Consult Clin Psychol; 2003 Jun; 71(3):432-42. PubMed ID: 12795568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude.
    Carroll KM; Sinha R; Nich C; Babuscio T; Rounsaville BJ
    Exp Clin Psychopharmacol; 2002 Feb; 10(1):54-63. PubMed ID: 11866252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in naltrexone treatment compliance with contingency management.
    Preston KL; Silverman K; Umbricht A; DeJesus A; Montoya ID; Schuster CR
    Drug Alcohol Depend; 1999 Apr; 54(2):127-35. PubMed ID: 10217552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.
    Johansson BA; Berglund M; Lindgren A
    Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.
    Sullivan MA; Bisaga A; Glass A; Mishlen K; Pavlicova M; Carpenter KM; Mariani JJ; Levin FR; Nunes EV
    Drug Alcohol Depend; 2015 Feb; 147():122-9. PubMed ID: 25555621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
    Klein AA; Seppala MD
    J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence.
    Church SH; Rothenberg JL; Sullivan MA; Bornstein G; Nunes EV
    Am J Drug Alcohol Abuse; 2001 Aug; 27(3):441-52. PubMed ID: 11506261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral naltrexone therapy: an integrated treatment for opiate dependence.
    Rothenberg JL; Sullivan MA; Church SH; Seracini A; Collins E; Kleber HD; Nunes EV
    J Subst Abuse Treat; 2002 Dec; 23(4):351-60. PubMed ID: 12495797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia.
    Kirtadze I; Otiashvili D; O'Grady KE; Jones HE
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):171-5. PubMed ID: 22221277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care.
    Otiashvili D; Kirtadze I; O'Grady KE; Jones HE
    Drug Alcohol Depend; 2012 Jan; 120(1-3):14-21. PubMed ID: 21742445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone pharmacotherapy for opioid dependent federal probationers.
    Cornish JW; Metzger D; Woody GE; Wilson D; McLellan AT; Vandergrift B; O'Brien CP
    J Subst Abuse Treat; 1997; 14(6):529-34. PubMed ID: 9437624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in naltrexone implant treatment for opioid dependence.
    Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen O; Waal H
    Drug Alcohol Depend; 2010 Sep; 111(1-2):166-9. PubMed ID: 20570059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
    Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
    N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.